期刊文献+

洛沙坦对肾大部分切除肾功能衰竭大鼠心脏的保护作用

Cardioprotective effect of losartan on subtotal nephrectomy renal failure rats
原文传递
导出
摘要 目的探讨洛沙坦对肾大部分切除肾功能衰竭(肾衰)大鼠心脏的保护作用。方法肾大部切除制备肾衰模型(RF组),治疗组(RF+Los组)洛沙坦剂量为10mg·kg-1·d-1灌胃,对照组(Sham组)用生理盐水灌喂。第12周观察实验动物心脏的有关变化。结果RF组大鼠动脉收缩压显著升高,心肌细胞肥大,心肌间质纤维化,而RF+Los组收缩压得到控制,心肌细胞肥大和心肌间质纤维化程度明显减轻。RF+Los组血管紧张素Ⅱ-1型受体(AT1R)mRNA的表达则较RF组显著下调(P<0.05)。结论洛沙坦通过阻断AT1R抑制肾素-血管紧张素系统(RAS)而具有明显的降压及防治肾大部分切除肾衰大鼠左心室肥厚和心肌间质纤维化的作用。 Objective To investigate the cardioprotective effect of losartan o n subtotal nephrectomy renal failure rats. Methods Renal failure rats were estab lished by subtotal nephrectomy, and then divided into RF group with subtotal nep hrectomy,RF+Los group with additional losartan(10 mg·kg-1·d-1) gavage. Rats underwent sham operation(sham group) with normal saline gavage as control. Hear t changes of experimental rats were observed 12 weeks after operation. Results T he RF group developed hypertension of arterial systolic blood pressure(SBP) and myocardiac myocytes hypertrophy. The levels of collagen type Ⅰ,type Ⅲ,and fi bronectin in endocardium and surrounding intracardial coronary arteries adventit ia of the RF group were significantly increased as compared to those of the sham group. The SBP and the levels of collagen type Ⅰ,Ⅲand fibronectin were marked ly decreased in the RF+Los group as compared to those of the RF group.Expressio n of angiotensin Ⅱsubtype 1 receptor (AT1R) mRNA in the myocardium of the RF+L os group was significantly down regulated as compared to that of RF group. Concl usions Losartan can prevent the cardiac ventricular remodeling with left ventric ular hypertrophy (LVH) and myocardial interstitial fibrosis by the depression of renin-angiotensin system through the down-regulation of myocardiac AT1R mRNA.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2004年第4期273-276,共4页 Chinese Journal of Nephrology
关键词 洛沙坦 肾功能衰竭 大鼠 心脏 心室肥大 心肌间质纤维化 并发症 Losartan Renal failure Ventricular hypertrophy,left Myocardial interstitial fibrosis
  • 相关文献

参考文献13

  • 1Massry SG, Smogorzewski M. The heart in uremia. Semin Nephrol, 1996, 16: 214-221.
  • 2Silberberg JS, Racine N, Barre P, et al. Regression of left ventricular hypertrophy in dialysed patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol,1990,6: 1-4.
  • 3Gretz N, Meisinger E, Stuauch M. Partial nephrectomy and chronic renal failure: the "mature" rat model. Contrib Nephrol, 1988, 60:46-55.
  • 4Choozynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem, 1987, 163: 156-162.
  • 5Terda Y, Tomita K, Nonoguchi H, et al. Expression of endothelium-3 mRNA along rat nephron segments using polymerase chain reaction. Kidney Int, 1993, 44: 1273-1281.
  • 6Terda Y, Tomita K, Nonoguchi H, et al. PCR localization of angiotensin Ⅱ receptor and angiotensinogen mRNAs in rat kidney.Kidney Int, 1993, 43: 1251-1259.
  • 7Mckinney M, Robbins M. Chronic atropine administration up-regulates rat cortical muscarinic ml receptor mRNA molecules:assessment with RT/PCR. Brain Res Mol Brain Res, 1992, 12:39-45.
  • 8Cohn JN. Structural changes in cardiovascular disease. Am J Cardiol, 1995, 76: 34E-37E.
  • 9Mall G, Huther W, Schneider J, et al. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant, 1990, 5:39-44.
  • 10盛斌,蔡启德,尹良红.尿毒症心脏损害的机制与研究进展[J].中国病理生理杂志,2003,19(5):712-716. 被引量:12

二级参考文献26

  • 1陈兰英.心脏肾素-血管紧张素系统与心肌肥厚[J].心血管病学进展,1996,17(6):336-339. 被引量:17
  • 2宋海燕,曾宪惠,刘鸣旺,迟月明,万汇涓.肉毒碱对实验性心肌损伤线粒体呼吸酶的影响[J].哈尔滨医科大学学报,1997,31(1):37-38. 被引量:23
  • 3吴国荃.慢性肾功能衰竭及替代治疗[M].北京:北京出版社,1998.107-108.
  • 4Vesa K Virtsnen, Heikki HT Saha, Kaj WE. Groundstroem,et al. Calcium infusion and left ventricular diastolic function in patients with chronic renal failure[ J]. Nephrol Dial Tran,1999,13(2) :384 - 388.
  • 5Hans R,Brunner. Experimental and clinical evidence that angiontensin Ⅱ is an independent risk factor for cardiovascullar disease[ J] .Am J Cardiology,2001,87(8):3- 9.
  • 6Watanabe K, Aizawa Y, Shibata A,et al.Depression of heart funcyion after angiotensin Ⅱ infusion in patients on chronic hemodialysis[ J] .Clin Exp Dial Apheresis, 1981,5(4) :249-259.
  • 7Sadoshima J, Izumo S. Molecular characterization angiotensin Ⅱ- induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype[J]. Circ Res, 1993(3) :412 - 423.
  • 8Kerstin Amann, Peter Gassmann, Moriz Buzello, et al. Effects of ACE inhibition and bradykinin antagonism on cardiovascular changes in uremic rat[J] .Kidney Int,2000,58(1):153-161.
  • 9Valerie Robert, Christophe Heymes,Jea- Sebastien Slivestre,et al. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone[J]. Hypertension, 1999,33(4) :981 - 986.
  • 10Sate A,Suzuki Y, Saruta T. Effects of spironolactone and angiotensin- converting enzyme inhibitor on left ventricular hypertrophy in patients with essential hypertensin[J]. Hypertens Res, 1999,22(4) : 17 - 22.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部